The targeted depletion of exogenous arginine by utilizing arginine-catabolizing enzymes (including arginase, arginine decarboxylase and arginine deiminase) has been well-recognized as an effective therapy against cancers with arginine auxotroph, especially melanoma [47]. Here, AZIN2 is linked to cancer.